Target intelligence / Profile preview

Heavy metal absorption

Molecular classification
Other (Biological process, not a single molecular entity), Involves Transporter (e.g., ABC transporters, divalent metal transporters, P-type ATPases), Involves Metal-binding protein (e.g., metallothionein, histidine-rich proteins)
01

Overview

Heavy metal absorption is the process by which living organisms take up and accumulate heavy metals from their environment through specific and non-specific transporters and binding proteins. In higher organisms (including humans), absorption primarily occurs across the intestinal tract, where heavy metals may exploit native metal transport pathways (such as via Divalent Metal Transporter 1 [DMT1], ZIP14, ATP7A, and specific ABC transporters)[1][2]. Once absorbed, metals may bind to proteins like metallothioneins or glutathione, which sequester and detoxify them to varying extents[1][2][4]. Disruption of these processes contributes to metal toxicity, as heavy metal ions can mimic or displace essential metals, perturb enzyme activity, damage DNA and membranes, and induce oxidative stress[4][5]. Absorption and storage mechanisms vary considerably by organism and metal species, with substantial involvement of cytosolic and membrane-associated proteins[1][2][4][5]. "Heavy metal absorption" is therefore a complex physiological process involving numerous specific molecular targets, rather than a single defined molecular entity.

02

Mechanism of action

Chelation and enhanced excretion of absorbed heavy metals by chelating agents Competitive inhibition or blockade of metal transporters to limit uptake

03

Biological functions

Metal ion homeostasisDetoxificationCellular uptake and storage of metalsStress response
04

Disease associations

Toxicity (Heavy metal poisoning)Neurodegeneration (via protein/enzyme inhibition)Kidney and liver injuryDisruption of trace element metabolism (mimicking of essential metals)Cancer and cardiovascular disease (long-term exposure effects)
05

Safety considerations

Toxicity to kidney, liver, nervous systemDisruption of homeostasis for essential metalloproteinsRisk of essential trace element deficiency due to transporter competition
06

Interacting drugs

Chelating agents (e.g., dimercaprol, EDTA, D-penicillamine; used for heavy metal detoxification)
07

Biomarkers

Metallothionein induction in blood and tissueElevated levels of heavy metals in urine or tissueOxidative stress markers (e.g., glutathione depletion, lipid peroxidation)

Beyond the preview

Go deeper on Heavy metal absorption.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heavy metal absorption.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call